Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl esters reduced plasma cholesterol and changed the fatty acid composition in rat blood and organs
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Fish oils rich in n‐3 fatty acids have been shown to decrease plasma lipid levels, but the underlying mechanism has not yet been elucidated. This investigation was performed in order to further clarify the effects of purified ethyl esters of eicosapentaenoic acid (EPA‐EE) and docosahexaenoic acid (DHA‐EE) on lipid metabolism in rats. The animals were fed EPA‐EE, DHA‐EE, palmitic acid, or corn oil (1 g/kg/d) by orogastric intubation along with a chow background diet for three months. At the end the animals were sacrificed. Plasma and liver lipids were measured, as well as lipid‐related enzyme activities and mRNA levels. The fatty acid composition of plasma and different tissues was also determined. This study shows that, compared to the corn oil control, EPA‐EE and DHA‐EE lowered plasma cholesterol level, whereas only EPA‐EE lowered the amount of plasma triacylglycerol. In liver peroxisomes, both EE preparations increased fatty acyl‐CoA oxidase FAO activities, and neither altered 3‐hydroxy‐3‐methylglutaryl (HMG)‐CoA reductase activities. In liver microsomes, EPA‐EE raised HMG‐CoA reductase and acyl‐CoAicholesterol acyltransferase activities, whereas DHA‐EE lowered the former and did not affect the latter. Neither product altered mRNA levels for HMG‐CoA reductase, low density lipoprotein‐receptor, or low density lipoprotein‐receptor related protein. EPA‐EE lowered plasma triacylglycerol, reflecting lowered very low density lipoprotein secretion, thus the cholesterol lowering effect in EPA‐EE‐treated rats may be secondary to the hypotriacylglycerolemic effect. An inhibition of HMG‐CoA reductase activity in DHA‐EE treated rats may contribute to the hypocholesterolemic effect. The present study reports that 20∶5n‐3, and not 22∶6n‐3, is the fatty acid primarily responsible for the triacylglycerol lowering effect of fish oil. Finally, 20∶5n‐3 was not converted to 22∶6n‐3, whereas retroconversion of 22∶6n‐3 to 20∶5n‐3 was observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review
Harris, W. S. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38310-3 · Cited by 1,127
Wong, S. H., Fisher, E. A., & Marsh, J. B. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.6.836 · Cited by 91
Cited by
Fish oil replacement in finfish nutrition
Turchini, G. M., Torstensen, B. E., & Ng, W. (2009) · Reviews in Aquaculture · doi:10.1111/j.1753-5131.2008.01001.x · Cited by 1,241
Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms
Larsson, S. C., Kumlin, M., Ingelman-Sundberg, M., & Wolk, A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.935 · Cited by 950
Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., O’Neal, D. N., Best, J. D., & Beilin, L. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1085 · Cited by 588
Mori, T. A., Bao, D. Q., Burke, V., Puddey, I. B., & Beilin, L. J. (1999) · Hypertension · doi:10.1161/01.hyp.34.2.253 · Cited by 407
Kim, H.-J., Takahashi, M., & Ezaki, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25892 · Cited by 377
Metadata
- Authors
- Frøyland, L., Vaagenes, H., Asiedu, D. K., Garras, A., Lie, Ø., & Berge, R. K.
- Venue
- Lipids
- Publisher
- Wiley
- Published
- 1996-02
- Volume
- 31
- Issue
- 2
- Pages
- 169-178
- ISSN
- 0024-4201 (ISSN-L)
- 1558-9307
- OpenAlex
- W2034715564
- Cited by
- 107
- References
- 3
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.